• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Anthera Pharmaceuticals, Inc. (ANTH)

    -NasdaqGM
    5.84 Up 0.07(1.21%) 4:00PM EDT
    Add to Portfolio
    Prev Close:5.77
    Open:5.78
    Bid:5.80 x 10000
    Ask:6.49 x 200
    1y Target Est:7.50
    Beta:1.11
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:5.65 - 5.99
    52wk Range:1.46 - 6.37
    Volume:565,599
    Avg Vol (3m):822,288
    Market Cap:209.17M
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ANTH

    Comparison

    Symbol% ChgMkt Cap
    ANTHUp 1.21%209.17M
    BIIBDown 1.46%91.18B
    GSKUp 0.20%106.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):843.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for patients with unmet medical needs. It is developing blisibimod, a Phase III product candidate that targets B-cell activating factor... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback